• Biocartis announces planned operational reorganization and cost reduction program

    Friday June 16th 2023

  • Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer

    Friday June 16th 2023

  • Mithra announces new positive preclinical data from CSF-1R inhibitor program

    Thursday June 15th 2023

  • My Pathomation new release at the ECDP

    Wednesday June 14th 2023

  • Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board

    Tuesday June 13th 2023

  • ΛCTIV by Aphea.Bio® launched in Poland

    Monday June 12th 2023

  • Oxurion finalizes enrollment in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema

    Monday June 12th 2023

  • SANTERO announces a €8 million Series A funding round led by Newton Biocapital to develop novel antibiotics in the fight against antimicrobial resistance

    Wednesday June 7th 2023

  • Your news here?

  • HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform

    Tuesday June 6th 2023

  • ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

    Monday June 5th 2023

  • Biotalys continues to demonstrate strength of first biocontrol in latest global field trials

    Friday June 2nd 2023

Strategic Partners